SEC Company Response from BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063) — May 29, 2024
BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
Date: May 29, 2024 · CIK: 0001580063 · Accession: 0001193125-24-149167
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279539
Letter
Biora Therapeutics, Inc.
4330 La Jolla Village Drive, Suite 300
San Diego, CA 92122
(833) 727-2841
May 29, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Re: Biora Therapeutics, Inc.
Registration Statement on Form S-3 (File No. 333-279539)
To Whom it May Concern:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Biora Therapeutics, Inc. (the “Company”) hereby requests that the effective date of the above referenced registration statement (the “Registration Statement”) be accelerated to May 31, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Gibson, Dunn & Crutcher LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its obligations under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Gibson, Dunn & Crutcher LLP by calling Stewart McDowell at (415) 393-8322.
Very truly yours,
Biora Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Biora Therapeutics, Inc. 4330 La Jolla Village Drive, Suite 300 San Diego, CA 92122 (833) 727-2841 May 29, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Re: Biora Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-279539) To Whom it May Concern: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Biora Therapeutics, Inc. (the “Company”) hereby requests that the effective date of the above referenced registration statement (the “Registration Statement”) be accelerated to May 31, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Gibson, Dunn & Crutcher LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its obligations under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Gibson, Dunn & Crutcher LLP by calling Stewart McDowell at (415) 393-8322. Very truly yours, Biora Therapeutics, Inc. By: /s/ Aditya P. Mohanty Name: Aditya P. Mohanty Title: Chief Executive Officer cc: Stewart McDowell, Gibson, Dunn & Crutcher LLP